ACD857
/ AlzeCure
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 15, 2020
AlzeCure enters the next development phase with ACD857 for Alzheimer's disease
(PharmiWeb)
- "AlzeCure Pharma...today announced that the company has begun a preclinical development phase with the company's drug candidate ACD857."
Preclinical • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1